Dr. Robert W. Sobol is Kearney's Advisor re Health Care Data; Point Clear Charities Professor Pharmacology and Chief, Molecular & Metabolic Oncology Program, Mitchell Cancer Institute, University of South Alabama.

He received a PhD in Biochemistry from Temple University School of Medicine. From 2002 through 2014, Dr. Sobol was a faculty member at the University of Pittsburgh, was a member of the University of Pittsburgh Cancer Institute (UPCI) and a scientific member of both the Molecular and Cellular Biology Program and the Brain Tumor Program at UPCI. Further, Dr. Sobol was the Director of the UPCI Lentiviral Facility and co-Director of the UPCI Vector Core Facility. During this time, Dr. Sobol also held an academic appointment in the Department of Pharmacology & Chemical Biology at the University of Pittsburgh, School of Medicine and a secondary appointment in the Department of Human Genetics (School of Public Health).

Since 2014, Dr. Sobol is the Point Clear Charities Professor in the Department of Pharmacology at the University of South Alabama (USA) and is the Chief of the Molecular & Metabolic Oncology Program at the USA / Mitchel Cancer Institute (MCI).

Dr. Sobol has been awarded the Seth Harris Feldman Chair of Research in 2007 and in 2008 from the National Brain Tumor Society and was appointed as a Hillman Fellow for Innovative Cancer Research in 2010 for basic research on DNA Repair as potential therapeutic targets in brain cancer. He has authored more than 115 scientific publications in distinguished journals in the fields of cancer biology and his work has garnered over 10,300 citation references. Dr. Sobol’s research has been recognized with grants from the US National Institutes of Health, the American Cancer Society, the Susan G. Komen Breast Cancer Foundation, the Brain Tumor Society, the Pittsburgh Foundation and the Elsa U. Pardee Foundation for Cancer Research, among others. From September 2017, Dr. Sobol held the position as President of the Environmental Mutagenesis and Genomics Society (EMGS) and then Past-President, finishing that post in September 2019. Dr. Sobol has served as chair of the DNA Mechanisms of Cancer Study section at the American Cancer Society and was the chair and a standing member of the NIH Cancer Etiology Study section through July 2020.